A Clinical Chemist's Perspective of the Benefits and Limitations of Fecal Calprotectin Testing

Presented By:
Dr. Lisa Johnson

Speaker Biography:
Dr. Johnson is a medical director in clinical chemistry at ARUP Laboratories and an assistant professor in the Department of Pathology at the University of Utah in Salt Lake City. She specializes in esoteric testing that includes non-infectious gastrointestinal assays, advanced lipid analyses, and maternal serum screening. She received her doctorate in organic chemistry from the University of Wisconsin- Madison, performed post-doctoral research at UCLA, and completed her clinical chemistry fellowship training at the University of Minnesota.

Webinar:
A Clinical Chemist's Perspective of the Benefits and Limitations of Fecal Calprotectin Testing

Webinar Abstract:
Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor patients with inflammatory bowel disease (IBD). Additionally Fecal Calprotectin can help differentiate the presence of inflammatory bowel disease from irritable bowel syndrome (IBS). Although the results are very useful for patients with IBD, there are some challenges that the clinical lab should be aware of when performing this testing in house. This presentation will discuss some of the benefits and limitations of the pre-analytical, analytical, and post-analytical processes for fecal calprotectin testing.

Earn PACE Credits:

LabRoots on Social:
SnapChat: labroots_inc